FIELD: chemistry.
SUBSTANCE: present invention relates to compounds and their pharmaceutically acceptable salts, which are disclosed in the patent claim.
EFFECT: compounds of the invention are useful as inhibitors of O-linked N-acetylglucosaminidase (O-GlcNAc-daza) and can be useful for treating certain disorders, such as Alzheimer's disease.
7 cl, 4 tbl, 120 ex
Title | Year | Author | Number |
---|---|---|---|
SELECTIVE GLYCOSIDASE INHIBITORS AND USE THEREOF | 2011 |
|
RU2592285C2 |
SELECTIVE GLYCOSIDASE INHIBITORS AND USE THEREOF | 2011 |
|
RU2609210C2 |
SELECTIVE GLYCOSIDASE INHIBITORS AND THEIR APPLICATION | 2012 |
|
RU2625308C2 |
GLYCOSIDASE INHIBITORS AND THEIR APPLICATIONS | 2013 |
|
RU2672873C2 |
MACROCYCLIZATION REACTIONS AND INTERMEDIATE COMPOUNDS AND OTHER FRAGMENTS SUITABLE FOR PREPARING ANALOGUES OF HALICHONDRIN B | 2014 |
|
RU2710545C2 |
RMT5 INHIBITORS | 2019 |
|
RU2814198C2 |
AMIDES OF CONDENSED PIPERIDINE AS MODULATORS OF ION CHANNELS | 2014 |
|
RU2741810C2 |
SHIP1 MODULATORS AND METHODS RELATED THERETO | 2014 |
|
RU2679805C2 |
PRINCE REACTION AND INTERMEDIATE PRODUCTS USED IN SYNTHESIS OF HALICHONDRIN MACROLIDES AND THEIR ANALOGUES | 2017 |
|
RU2777913C2 |
CONDENSED AMINOHYDROTHIAZINE DERIVATIVE | 2009 |
|
RU2476431C2 |
Authors
Dates
2019-11-26—Published
2013-05-03—Filed